150 related articles for article (PubMed ID: 23708011)
1. Sulphonamido-quinoxalines: search for anticancer agent.
Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a new series of 4-chloro-2-mercapto-5-methylbenzenesulfonamide derivatives with potential antitumor activity.
Sławiński J
Eur J Med Chem; 2004 Feb; 39(2):179-88. PubMed ID: 14987826
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
El-Hawash SA; Wahab AE
Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
[TBL] [Abstract][Full Text] [Related]
6. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
Zarranz B; Jaso A; Aldana I; Monge A
Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
Lee YB; Gong YD; Kim DJ; Ahn CH; Kong JY; Kang NS
Bioorg Med Chem; 2012 Feb; 20(3):1303-9. PubMed ID: 22226981
[TBL] [Abstract][Full Text] [Related]
11. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antitumor activity of new quinoxaline derivatives.
Corona P; Carta A; Loriga M; Vitale G; Paglietti G
Eur J Med Chem; 2009 Apr; 44(4):1579-91. PubMed ID: 18774202
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors.
Wu P; Su Y; Liu X; Yang B; He Q; Hu Y
Bioorg Med Chem; 2012 May; 20(9):2837-44. PubMed ID: 22480851
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives.
Sławiński J; Brzozowski Z
Eur J Med Chem; 2006 Oct; 41(10):1180-9. PubMed ID: 16777268
[TBL] [Abstract][Full Text] [Related]
15. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives.
Moorthy NS; Karthikeyan C; Trivedi P
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):394-405. PubMed ID: 20233012
[TBL] [Abstract][Full Text] [Related]
17. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
18. Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents.
Hu L; Li ZR; Wang YM; Wu Y; Jiang JD; Boykin DW
Bioorg Med Chem Lett; 2007 Mar; 17(5):1193-6. PubMed ID: 17197178
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
Moarbess G; Deleuze-Masquefa C; Bonnard V; Gayraud-Paniagua S; Vidal JR; Bressolle F; Pinguet F; Bonnet PA
Bioorg Med Chem; 2008 Jul; 16(13):6601-10. PubMed ID: 18513976
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
